Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat relapsing MS. The results of ophthalmic evaluations during clinical studies of fingolimod in patients with MS are reported
Multiple sclerosis is an autoimmune inflammatory disease of the central nervous system with neurodeg...
Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocyte...
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR ...
WOS: 000419248500004Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous s...
Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress fr...
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR ...
FTY720, also known as fingolimod, is an orally administered sphingosine-1-phosphate (S1P) analogue t...
Background no treatments have been approved for primary progressive multiple sclerosis. Fingolimod, ...
BACKGROUND Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyt...
Fingolimod (FTY720), a sphingosine 1-phosphate receptor modulator, is the first in a new class of th...
Background: Fingolimod is a modulator of Central and peripheral sphingosine pathways, which is curre...
Multiple sclerosis is an autoimmune inflammatory disease of the central nervous system with neurodeg...
Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocyte...
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR ...
WOS: 000419248500004Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous s...
Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress fr...
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR ...
FTY720, also known as fingolimod, is an orally administered sphingosine-1-phosphate (S1P) analogue t...
Background no treatments have been approved for primary progressive multiple sclerosis. Fingolimod, ...
BACKGROUND Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyt...
Fingolimod (FTY720), a sphingosine 1-phosphate receptor modulator, is the first in a new class of th...
Background: Fingolimod is a modulator of Central and peripheral sphingosine pathways, which is curre...
Multiple sclerosis is an autoimmune inflammatory disease of the central nervous system with neurodeg...
Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocyte...
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR ...